18F-FDG PET/CT in Pediatric ALK-Positive Histiocytosis With Isolated CNS Involvement

被引：0
|
作者：
Singh, Karan [1 ]
London, Kevin [2 ]
Ryan, Jessica [3 ]
Wright, Dale C. [4 ,5 ]
Moghimi, Ali [6 ,7 ]
机构：
[1] Childrens Hosp Westmead, Sydney Childrens Hosp Network, Dept Nucl Med, Westmead, NSW 4001, Australia
[2] Univ Sydney, Fac Med & Hlth, Sydney Sch Hlth Sci, Discipline Med Imaging Sci, Sydney, NSW, Australia
[3] Childrens Hosp Westmead, Canc Ctr Children, Westmead, NSW, Australia
[4] Childrens Hosp Westmead, Sydney Genome Diagnost, Cytogenet, Westmead, NSW, Australia
[5] Univ Sydney, Fac Med & Hlth, Specialty Genom Med, Sydney, NSW, Australia
[6] Childrens Hosp Westmead, Dept Histopathol, Westmead, NSW, Australia
[7] Univ Sydney, Childrens Hosp Westmead, Fac Med & Hlth, Clin Sch, Westmead, NSW, Australia
来源：
CLINICAL NUCLEAR MEDICINE | 2024年 / 49卷 / 10期
关键词：
ALK-positive histiocytosis; pediatrics; FDG PET/CT;
D O I：
10.1097/RLU.0000000000005302
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
An 11-year-old girl presented with focal impaired awareness seizures. MRI brain demonstrated a T2 hyperintense cortical lesion in the left temporal lobe with surrounding vasogenic edema.F- 18-FDG PET/CT was arranged to assess metabolic activity of the cerebral lesion, to screen the whole body for other metabolically active lesions, and to assist biopsy planning. The study demonstrated intensely increased FDG uptake within the left temporal lobe lesion without evidence of hypermetabolic lesions elsewhere on the whole-body acquisition. The brain lesion was excised, and histopathology and molecular testing were consistent with ALK-positive histiocytosis.
引用
收藏
页码：e506 / e508
页数：3
相关论文
共 50 条
  • [41] The baseline metabolism parameters of 18F-FDG PET/CT as promising prognostic biomarkers in pediatric Langerhans cell histiocytosis
    Lu, Xia
    Wei, Ang
    Wang, Guanyun
    Du, Junye
    Feng, Lijuan
    Ou, Wenxin
    Wang, Tianyou
    Wang, Wei
    Li, Jixia
    Zhang, Mingyu
    Zhang, Rui
    Yang, Jigang
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2023, 13 (09) : 5934 - 5944
  • [42] 18F-FDG PET/CT in pediatric lymphoma patients: the role of technologist
    Ciaccio, M.
    Nava, C.
    Bonacina, D.
    Maurizio, M.
    Perri, A.
    Renaioli, A.
    Morzenti, S.
    Guerra, L.
    Crivellaro, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S220 - S221
  • [43] Research for 18F-FDG PET/CT in the diagnosis of recurrent pediatric neuroblastoma
    Chen, Yumei
    Huang, Gang
    Liu, Jianjun
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [44] The role of 18F-FDG PET/CT in the evaluation of pediatric transplant patients
    Yang, Jigang
    Zhuang, Hongming
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2015, 18 (02): : 136 - 139
  • [45] Added predictive value of 18F-FDG PET/CT for pediatric rhabdomyosarcoma
    El-Kholy, Esraa
    EL Nadi, Enas
    Hafez, Hanafy
    Ahmed, Soha
    Younes, Alaa
    EL-Kenanii, Naglaa
    Khalid, Elham
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (09) : 898 - 904
  • [46] OctreotideFalse positive 18F-FDG PET/CT imaging: case report
    Reactions Weekly, 2017, 1634 (1) : 209 - 209
  • [47] Role of 18F-FDG PET/CT in the Staging of Pediatric Peritoneal Mesothelioma
    Abikhzer, Gad
    Gourevich, Konstantin
    Arkovitz, Marc
    Postovsky, Sergey
    Keidar, Zohar
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (08) : E331 - E332
  • [48] RituximabFalse positive 18F-FDG PET/CT imaging: case report
    Reactions Weekly, 2016, 1609 (1) : 106 - 106
  • [49] Isolated Muscular Sarcoidosis Revealed by Hypercalcemia and 18F-FDG PET/CT
    Dhomps, Anthony
    Foret, Thibault
    Streichenberger, Nathalie
    Skanjeti, Andrea
    Tordo, Jeremie
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (10) : 824 - 825
  • [50] Identification of Isolated Hepatic Sarcoidosis With 18F-FDG PET/CT and MRI
    Arnfield, Evyn
    Pattison, David A.
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (09) : E448 - E450
12345